Global and United States Proton Pump Inhibitors Market Insights, Forecast to 2027
- September 2021
- 148 pages
Proton pump inhibitors (PPIs) reduce the production of acid by blocking the enzyme in the wall of the stomach that produces acid. Acid is necessary for the formation of most ulcers in the esophagus, stomach, and duodenum, and the reduction of acid with PPIs prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal.
PPIs are among the most widely sold medications in the world. The class of proton-pump inhibitor medications is on the World Health Organization's List of Essential Medicines.
Medically used proton pump inhibitors: Omeprazole, Lansoprazole, Dexlansoprazole, Esomeprazole, Pantoprazole, Rabeprazole.
Global Proton Pump Inhibitors key players include AstraZeneca, Takeda, etc. Global top two manufacturers hold a share over 15%.
North America is the largest market, with a share about 30%, followed by Asia-Pacific, and Europe, having a share about 50 percent.
In terms of product, Esomeprazole is the largest segment, with a share about 30%. And in terms of application, the largest application is Hospital Pharmacy, followed by Retail Pharmacy, etc.
Market Analysis and Insights: Global and United States Proton Pump Inhibitors Market
This report focuses on global and United States Proton Pump Inhibitors market.
In 2020, the global Proton Pump Inhibitors market size was US$ 12810 million and it is expected to reach US$ 10030 million by the end of 2027, with a CAGR of -3.2% during 2021-2027. In United States the Proton Pump Inhibitors market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Proton Pump Inhibitors Scope and Market Size
Proton Pump Inhibitors market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Proton Pump Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Proton Pump Inhibitors market size by players, by Type, and by Distribution Channel, for the period 2016-2027. The key players include the global and local players which play important roles in United States.
Segment by Type
Segment by Distribution Channel
Middle East & Africa
Product Type & Applications
- Sun Pharma
- Eisai Co.
- AOSAIKANG Pharma
- Luoxin Pharma
- Eastchina Pharma
- Proton Pump Inhibitors
- Hospital Pharmacy
- Retail Pharmacy
Have query on this report?Make an Enquiry
1.1 Proton Pump Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global Proton Pump Inhibitors Market Size Growth Rate by Type
Table 1. Global Proton Pump Inhibitors Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Dexlansoprazole
Table 3. Major Manufacturers of Esomeprazole
Table 4. Major Manufacturers of Lansoprazole
Table 5. Major Manufacturers of Omeprazole
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017